Article
Transcriptomic Profiling of MSI-H/dMMR Gastrointestinal Tumors to Identify Determinants of Responsiveness to Anti-PD-1 Therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research - 13 May 2022
Chida Keigo, Kawazoe Akihito, Suzuki Toshihiro, Kawazu Masahito, Ueno Toshihide, Takenouchi Kazumasa, Nakamura Yoshiaki, Kuboki Yasutoshi, Kotani Daisuke, Kojima Takashi, Bando Hideaki, Mishima Saori, Kuwata Takeshi, Sakamoto Naoya, Watanabe Jun, Mano Hiroyuki, Ikeda Masafumi, Shitara Kohei, Endo Itaru, Nakatsura Tetsuya, Yoshino Takayuki
Abstract excerpt
PURPOSE: Transcriptomic profiling was performed for microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) gastrointestinal tumors to determine the predictors of response to PD-1 blockade. EXPERIMENTAL DESIGN: Thirty-six patients with MSI-H/dMMR gastrointestinal tumors, including gastric cancer, colorectal cancer, cholangiocarcinoma, small intestine cancer, and pancreatic cancer, being treated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
